Webinar: Will Pharmacists Adopt New Vancomycin Guidelines? скачать в хорошем качестве

Webinar: Will Pharmacists Adopt New Vancomycin Guidelines?

New data from a recent market study shows that, while pharmacists overwhelmingly agree that recently released vancomycin dosing guidelines are important to patient safety, a minority have plans in place to adopt them. InsightRX surveyed 126 hospital pharmacy leaders to gauge their awareness of the guidelines, thoughts about the value of adopting them, and plans to implement. We put together a panel of experts from across the industry to share their insights: • Sirj Goswami, PhD: CEO & Co-Founder, InsightRX • Rita Jew, PharmD, FASHP: Principal, RKJ Health Partners • Julie Giddens, PharmD, BCPS-AQID, BCIDP: Ministry Infectious Disease Pharmacotherapy Coordinator, OSF Healthcare • Dan D’Orazio: CEO, Sage Growth Partners • Jeffery Laux, PharmD, BCIDP: Clinical Pharmacy Specialist, Covenant HealthCare This group will discuss the benefits and challenges of adopting these guidelines amid the current pandemic. Through a lively discussion, participants will gain new insights on how precision dosing can make a meaningful impact on patient safety—while improving cost and time savings for hospital pharmacies. View the market report here: https://bit.ly/2JDvjB7